One piece of evidence supporting the critical role of CD4+ T cells in ALS is the status of the BBB, wherein ALS progression leads to significant focal damage, as defined by the Zlokovic–Cleveland Model [53,54,55]. This evidence concerns the gene CD4 and amyotrophic lateral sclerosis.